Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13145877 | 0.90 | SLC2A1 (0.52) | SLC2A1KCNH2 | |
| SCHEMBL14514795 | 0.88 | SLC2A1 (0.52) | SLC2A1KCNH2 | |
| SCHEMBL3694581 | 0.86 | SLC2A1 (0.53) | SLC2A1KCNH2 | |
| SCHEMBL5652953 | 0.86 | SLC2A1 (0.53) | SLC2A1KCNH2 | |
| SCHEMBL3685796 | 0.86 | SLC2A1 (0.53) | SLC2A1KCNH2 | |
| SCHEMBL5647894 | 0.84 | SLC2A1 (0.53) | SLC2A1KCNH2 | |
| SCHEMBL3694794 | 0.84 | SLC2A1 (0.52) | SLC2A1KCNH2 | |
| SCHEMBL3687873 | 0.83 | SLC2A1 (0.49) | SLC2A1KCNH2 | |
| SCHEMBL13145818 | 0.83 | SLC2A1 (0.49) | SLC2A1KCNH2 | |
| SCHEMBL14434675 | 0.83 | SLC2A1 (0.56) | SLC2A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7223776-B2 | Compounds with anti-bacterial activity | MORPHOCHEM AG (DE) | 2007-05-29 | — | — | US | disclosed |
| US-20060040949-A1 | Novel compounds with antibacterial activity | MORPHOCHEM AG | 2006-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060040949-A1 | Novel compounds with antibacterial activity | MRPL21, Q6ZSR9, MRPL19 | SLC2A1 4070/4885KCNH2 2411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.